GLP1R and stroke disorder: More specifically, the IPCW analysis revealed a 31% reduction in risk of stroke, a 27% reduction in risk of MI, and a 29% reduction in risk of their composite in OW GLP-1 RA users compared with DPP-4i users (all P < 0.05).